Skip to main content

RenX Enterprises Corp. Issues Letter to Shareholders

MIAMI, FL, May 11, 2026 (GLOBE NEWSWIRE) — RenX Enterprises Corp. (NASDAQ: RENX) (“RenX” or the “Company”), a biomass recycling, logistics, and real estate company, today issued the following letter to shareholders: To Our Shareholders, This letter comes at a moment when we believe the case for what RenX is building is increasingly compelling. Recent geopolitical disruption has upended global agricultural input markets. Conflict-driven volatility has put pressure on key trade routes and pushed prices higher for fertilizer products such as urea, anhydrous ammonia, and phosphate, at exactly the moment Northern Hemisphere farmers prepare to plant. American producers are paying more, earning less, and questioning whether they will have enough of the inputs they need for upcoming planting seasons. The same forces driving up the cost...

Continue reading

The Boston Beer Company Lights Up Ready-To-Drink Market with All-New 15% Alc. LYTT® Electric Coolers™

Single-serve, full-flavored malt beverages are available in select markets now in resealable, recyclable, uniquely shaped, glow-in-the-dark containersLYTT® Electric Coolers™ Contains 15% ABVSingle-serve, full-flavored malt beverages are available in select markets now for drinkers 21+Introducing LYTT® Electric Coolers™Six flavors packaged in unique, patent pending lightbulb-shaped containers that are glow-in-the-dark, resealable, and widely recyclableBoston, May 11, 2026 (GLOBE NEWSWIRE) — The bright minds behind some of The Boston Beer Company’s biggest innovations today introduce LYTT® Electric Coolers™, the newest single-serve beverage to light up the growing ready-to-drink space. Packaged in unique, patent pending lightbulb-shaped containers that are glow-in-the-dark, resealable, and...

Continue reading

Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Highlighting Ovarian Cancer Landscape and Lead Candidate ERNA-101

Moderated discussion with Chief Scientific Officer Dr. Robert Pierce on ovarian cancer and evolving treatment landscape  Segment highlights significant unmet need in ovarian cancer and the potential of ERNA-101 to address limitations of current therapies Access the segment here Company to also participate in Virtual Investor Closing Bell event on May 13 featuring Sanjeev Luther and Dr. Robert Pierce Register for the Closing Bell event here  CAMBRIDGE, Mass., May 11, 2026 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the release of a Virtual Investor KOL Connect segment featuring Dr. Robert Pierce, Chief Scientific Officer of Ernexa.  As part of the segment, Dr. Pierce provides insight into...

Continue reading

Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors

Strengthens Leadership Team and Board with additional business development, finance and royalty management expertiseSAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced the appointment of Christopher Murphy as Chief Financial Officer and Owen Hughes as a member of its Board of Directors. “We are excited to welcome Chris, who will be fully dedicated to Anaptys, and Owen, both of whom deepen our team’s strong mix of expertise across finance, business development, royalty management and strategic transactions,” said Daniel Faga, president and chief executive officer. “We believe these strong additions will continue Anaptys’ focus on protecting and returning the value of our royalty assets...

Continue reading

WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model

Hangzhou, China, May 11, 2026 (GLOBE NEWSWIRE) — WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its subsidiaries in China, today announced that it has entered into a strategic cooperation agreement (the “Agreement”) with Shanghai Novabioplus Biotechnology Co., Ltd. (“Novabioplus”), a provider of biological reagent products and solutions on April 13, 2026. The two parties aim to jointly develop a “Data-Model-Application” trinity of next-generation intelligent medical models. The long-term initiative aims to integrate WORK Medical’s digital transformation of AI-driven healthcare with Novabioplus’ extensive protein data resources and application scenarios, unlocking the latent value of biological data assets. WORK Medical continues to deepen its...

Continue reading

Telos Corporation Announces First Quarter 2026 Earnings

ASHBURN, Va., May 11, 2026 (GLOBE NEWSWIRE) — Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, has posted its 2026 first quarter financial results on its investor relations website at https://investors.telos.com. Telos will host a live webcast to discuss its first quarter 2026 financial results today, May 11, 2026, at 9:30 a.m. ET. To access the webcast, visit https://edge.media-server.com/mmc/p/so4sxhaa. Related presentation materials will be available in the Investors section of the Company’s website. In addition, an archived webcast will be posted on the website approximately two hours after the live event concludes. About Telos CorporationTelos Corporation (NASDAQ: TLS) empowers and protects the world’s most security-conscious...

Continue reading

Coop Pank AS own shares acquisition transactions

Coop Pank AS (the Bank) announces that during the period 4.-10.05.2026, it has acquired the company’s own shares on the Nasdaq Tallinn Stock Exchange as follows:Date Aggregated volume (pcs) Weighted average price per day (EUR)06.05.2026 10,490 2.3062240207.05.2026 5,000 2.3200000008.05.2026 6,870 2.32000000 Bank is acquiring its own shares based on the resolution of the company’s general meeting of shareholders held on 8 April 2026, and under the conditions decided by the Supervisory Board and Management Board. Summary data of the acquisitions will be disclosed no later than on the seventh trading day after the transaction and will be made available to the Financial Supervision and Resolution Authority, via the Nasdaq Tallinn system, and on Coop Bank´s investor website. Additional information:Paavo TruuCFOPhone: 5160 231E-mail: paavo.truu@cooppank.ee Coop...

Continue reading

Coop partners with ZetaDisplay to roll out advanced in-store retail media network across Norway

ZetaDisplay-Coop Norway retail media roll-outCoop Norway and ZetaDisplay are expanding their partnership with the next phase of a nationwide in-store retail media network rollout across Coop Extra stores following a successful pilot.MALMÖ, ZETADISPLAY AB (PUBL) – 11 May 2026 Coop Norway and ZetaDisplay have entered the next phase of a strategic agreement after the successful roll out of a pilot earlier last year. The next phase includes an advanced in-store retail media network across its nationwide store portfolio. The agreement will focus on Coop’s Extra stores, with the intention of establishing a nationwide network marking a significant step in the retailer’s retail media strategy. As Norway’s second-largest grocery retailer, Coop Norway operates approximately 1,200 grocery and home improvement stores. The extended agreement...

Continue reading

CONVENING NOTICE TO THE ORDINARY GENERAL MEETING 2026 OF IBA SA

CONVENING NOTICE TO THE ORDINARY GENERAL MEETING 2026 OF IBA SA – WEDNESDAY, JUNE 10, 2026, AT 10:00 A.M. –Dear Shareholder, We have the honor of convening you to the Ordinary General Meeting (the “OGM“) of IBA to be held on Wednesday June 10, 2026 at 10:00 A.M., to deliberate on the attached agenda. The OGM will be held in person at the Company’s headquarters. There will also be an online webcast, accessible upon prior registration, but it will not be possible to vote online. This is a simple webcast. Shareholders are strongly encouraged to vote in advance of the OGM, within the legal deadlines, by proxy or via the remote voting form (both of which are provided herewith), in order to facilitate the counting of votes. Alternatively, shareholders are offered the possibility of voting via the platform http://www.abnamro.com/evoting...

Continue reading

Interlink Electronics, Inc. Announces Execution of Non-Binding Letter of Intent For Potential Strategic Acquisition

Completed Transaction Would Advance Strategic Growth and Expand Capabilities Across Critical Industries FREMONT, Calif., May 11, 2026 (GLOBE NEWSWIRE) — Interlink Electronics, Inc. (Nasdaq: LINK) (“Interlink” or the “Company”), a global leader in sensor technology and printed electronic solutions, today announced that it has entered into a non-binding letter of intent (“LOI”) for a potential strategic acquisition. The proposed acquisition target is an established provider of high-performance manufacturing solutions to customers operating in mission-critical sectors, including semiconductor, defense, laser and photonics, commercial high-tech, and aerospace. Based on information made available to the Company by the proposed target, the target generated more than $33 million in revenue and approximately $4 million in EBITDA for 2025. The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.